|
|
||||||||
Department of Immunology and Bacteriology, University of Glasgow, Glasgow, United Kingdom
One of the major unresolved questions in B cell biology is how the
B cell Ag receptor (BCR) differentially signals to transduce anergy,
apoptosis, proliferation, or differentiation during B cell maturation.
We now report that extracellularly regulated kinase-mitogen-activated
protein kinase (Erk-MAP kinase) can play dual roles in the regulation
of the cell fate of the immature B cell lymphoma, WEHI-231, depending
on the kinetics and context of Erk-MAP kinase activation. First, we
show that the BCR couples to an early (
2 h) Erk-MAP kinase signal
which activates a phospholipase A2 pathway that we have
previously shown to mediate collapse of mitochondrial membrane
potential, resulting in depletion of cellular ATP and cathepsin B
execution of apoptosis. Rescue of BCR-driven apoptosis by CD40
signaling desensitizes such early extracellularly regulated kinase
(Erk) signaling and hence uncouples the BCR from the apoptotic
mitochondrial phospholipase A2 pathway. A second role for
Erk-MAP kinase in promoting the growth and proliferation of WEHI-231
immature B cells is evidenced by data showing that proliferating and
CD40-stimulated WEHI-231 B cells exhibit a sustained cycling pattern
(848 h) of Erk activation that correlates with cell growth and
proliferation. This growth-promoting role for Erk signaling is
supported by three key pieces of evidence: 1) signaling via the BCR,
under conditions that induce growth arrest, completely abrogates
sustained Erk activation; 2) CD40-mediated rescue from growth arrest
correlates with restoration of cycling Erk activation; and 3) sustained
inhibition of Erk prevents CD40-mediated rescue of BCR-driven
growth arrest of WEHI-231 immature B cells. Erk-MAP kinase can
therefore induce diverse biological responses in WEHI-231 cells
depending on the context and kinetics of
activation.
This article has been cited by other articles:
![]() |
E. O. Lobo, Z. Zhang, and J. E. Shively Pivotal Advance: CEACAM1 is a negative coreceptor for the B cell receptor and promotes CD19-mediated adhesion of B cells in a PI3K-dependent manner J. Leukoc. Biol., August 1, 2009; 86(2): 205 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ivanov, S. Krysov, M. S. Cragg, and T. Illidge Radiation Therapy with Tositumomab (B1) Anti-CD20 Monoclonal Antibody Initiates Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase-Dependent Cell Death that Overcomes Resistance to Apoptosis Clin. Cancer Res., August 1, 2008; 14(15): 4925 - 4934. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ke, M. Gururajan, A. Kumar, A. Simmons, L. Turcios, R. L. Chelvarajan, D. M. Cohen, D. L. Wiest, J. G. Monroe, and S. Bondada The Role of MAPKs in B Cell Receptor-induced Down-regulation of Egr-1 in Immature B Lymphoma Cells J. Biol. Chem., December 29, 2006; 281(52): 39806 - 39818. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Poggianella, M. Bestagno, and O. R. Burrone The Extracellular Membrane-Proximal Domain of Human Membrane IgE Controls Apoptotic Signaling of the B Cell Receptor in the Mature B Cell Line A20 J. Immunol., September 15, 2006; 177(6): 3597 - 3605. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Hollmann, T. Owens, J. Nalbantoglu, T. J. Hudson, and R. Sladek Constitutive Activation of Extracellular Signal-Regulated Kinase Predisposes Diffuse Large B-Cell Lymphoma Cell Lines to CD40-Mediated Cell Death. Cancer Res., April 1, 2006; 66(7): 3550 - 3557. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Craxton, K. E. Draves, A. Gruppi, and E. A. Clark BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway J. Exp. Med., November 21, 2005; 202(10): 1363 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gururajan, R. Chui, A. K. Karuppannan, J. Ke, C. D. Jennings, and S. Bondada c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells Blood, August 15, 2005; 106(4): 1382 - 1391. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Herrin, A. L. Groeger, and L. B. Justement The Adaptor Protein HSH2 Attenuates Apoptosis in Response to Ligation of the B Cell Antigen Receptor Complex on the B Lymphoma Cell Line, WEHI-231 J. Biol. Chem., February 4, 2005; 280(5): 3507 - 3515. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Adams, A. M. Grierson, A. M. Mowat, M. M. Harnett, and P. Garside Differences in the Kinetics, Amplitude, and Localization of ERK Activation in Anergy and Priming Revealed at the Level of Individual Primary T Cells by Laser Scanning Cytometry J. Immunol., August 1, 2004; 173(3): 1579 - 1586. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Harnett CD40: A Growing Cytoplasmic Tale Sci. Signal., June 15, 2004; 2004(237): pe25 - pe25. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Guilbault and R. J. Kay RasGRP1 Sensitizes an Immature B Cell Line to Antigen Receptor-induced Apoptosis J. Biol. Chem., May 7, 2004; 279(19): 19523 - 19530. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Katz, C. Lord, C. A. Ford, S. B. Gauld, N. A. Carter, and M. M. Harnett Bcl-xL antagonism of BCR-coupled mitochondrial phospholipase A2 signaling correlates with protection from apoptosis in WEHI-231 B cells Blood, January 1, 2004; 103(1): 168 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jinquan, H. H. Jacobi, C. Jing, A. Millner, E. Sten, L. Hviid, L. Anting, L. P. Ryder, C. Glue, P. S. Skov, et al. CCR3 Expression Induced by IL-2 and IL-4 Functioning as a Death Receptor for B Cells J. Immunol., August 15, 2003; 171(4): 1722 - 1731. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ostrovsky and E. Bengal The Mitogen-activated Protein Kinase Cascade Promotes Myoblast Cell Survival by Stabilizing the Cyclin-dependent Kinase Inhibitor, p21WAF1 Protein J. Biol. Chem., May 30, 2003; 278(23): 21221 - 21231. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Muscarella and S. E. Bloom Cross-linking of Surface IgM in the Burkitt's Lymphoma Cell Line ST486 Provides Protection against Arsenite- and Stress-induced Apoptosis That Is Mediated by ERK and Phosphoinositide 3-Kinase Signaling Pathways J. Biol. Chem., January 31, 2003; 278(6): 4358 - 4367. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |